Eli Lilly has two press releases coming up next month, and considering the stability of this company, this could probably the easiest 10-20% you've ever made. The first press release is a phase 2 trial update for their drug, Donanemab (TRAILBLAZER-ALZ) for Alzheimer's. The second release is a meeting to schedule a PDUFA approval on the 24th. I will be selling after this meeting. Good Luck!
